{"name": "Eisai",
 "permalink": "eisai-co",
 "crunchbase_url": "http://www.crunchbase.com/company/eisai-co",
 "homepage_url": "http://www.eisai.co.jp",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "81(3)3817-5327",
 "description": "",
 "created_at": "Wed Jan 13 12:27:03 UTC 2010",
 "updated_at": "Fri Mar 11 03:38:55 UTC 2011",
 "overview": "\u003Cp\u003EEisai Co. place primary emphasis on patients and their families, they strive to increase the benefits that health care provides them and they conduct their business to meet their diversified health care needs worldwide. They aim to be Human Health Care (\u0026#8220;hhc\u0026#8221;) companies that make a meaningful contribution under any health care system through their business activities around the world.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       38],
      "assets/images/resized/0007/3196/73196v1-max-150x150.jpg"],
     [[187,
       48],
      "assets/images/resized/0007/3196/73196v1-max-250x250.jpg"],
     [[187,
       48],
      "assets/images/resized/0007/3196/73196v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Associate Vice President Oncology",
    "person":
     {"first_name": "Sandra",
      "last_name": "Silberman",
      "permalink": "sandra-silberman",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 255000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.eisai.co.jp/enews/enews201001.html",
    "source_description": "Eisai Completes Acquisition of AkaRx, Inc. in the United States",
    "acquired_year": 2010,
    "acquired_month": 1,
    "acquired_day": 7,
    "company":
     {"name": "AkaRx",
      "permalink": "akarx",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "4-6-10 Koishikawa, Bunkyo-ku",
    "address2": "",
    "zip_code": "112-8088",
    "city": "Tokyo ",
    "state_code": null,
    "country_code": "JPN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "H3 Biomedicine launches with $200M from Eisai",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 28,
    "source_url": "http://www.masshightech.com/stories/2011/01/24/daily54-H3-Biomedicine-launches-with-200M-from-Eisai.html",
    "source_text": "",
    "source_description": "H3 Biomedicine launches with $200M from Eisai",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Eisai",
      "permalink": "eisai-co"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        144],
       "assets/images/resized/0007/3199/73199v1-max-150x150.jpg"],
      [[250,
        241],
       "assets/images/resized/0007/3199/73199v1-max-250x250.jpg"],
      [[450,
        433],
       "assets/images/resized/0007/3199/73199v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}